Industry / Lithuania
Wholesale Market Attracts Foreign Investment
July 2008 | Industry NewsStrong growth in Lithuania's drug market and consolidation in the supply chain has attracted investment from one of Germany's largest wholesalers, Andreae-Noris Zahn (ANZAG). On July 15 2008 ANZAG acquired a majority stake in Lithuanian distributor Armila as part of the German firm's strategy to position itself in 'high growth markets'. BMI takes this opportunity to analyse the Lithuanian wholesale market and the opportunities that may lie ahead for
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
